Dogs with RVED develop retinal degeneration from around four years of age which, if untreated, leads to blindness.
In partnership with James Oliver, Head of Ophthalmology at DWR Veterinary Specialists (pictured), researchers set out to discover why some Cocker Spaniels have such low vitamin E levels in their blood, despite it being present at normal amounts in their diet
James helped to design the study, recruit cases and collect samples.
Cathryn Mellersh, Senior Research Associate at the Canine Genetics Centre, said: “The team strongly suspected a genetic cause and has been trying to discover the responsible gene for several years with the help of owners and vets, who have contributed DNA samples.
“Thanks to updated information on the canine genome, Katherine Stanbury, one of our research associates, found a mutation in the alpha tocopherol transfer protein gene which is causative of the disease.
“This gene is responsible for getting vitamin E into the blood stream.
"We now know that RVED is a recessive disease, meaning that affected dogs must have two copies of the faulty gene to develop low vitamin E levels and retinal degeneration.”
The team’s DNA test can be used by dog breeders to find out if dogs carry the gene mutation, so they can avoid matings which result in affected puppies being born.
Cathryn said: “This DNA test is a rare example of one which not only can be used to identify dogs that are carrying the mutation and thus reduce the frequency of the mutation in future generations, but also has the incredible benefit of providing a sight-saving treatment option for dogs with the disease.
“From the research we have done we estimate that there could be several hundred Cocker Spaniels alive today that have two copies of this mutation, whose eyesight could be saved by this test.”
A DNA test for the mutation that causes RVED is now available from Canine Genetics Testing, which operates alongside researchers from the Canine Genetics Centre.
www.cagt.co.uk.
The team’s RVED research can be viewed at https://academic.oup.com/g3journal/advance-article/doi/10.1093/g3journal/jkaf016/7985679?searchresult=1
This year's event, titled “Nourish the Gut, Nurture the Future,” will have talks from over 17 experts, including:
Dr. Karen Shenoy, US Chief Veterinary Officer at Hill’s Pet Nutrition said: “The microbiome is a trending focus in human health, and Hill’s Pet Nutrition is proud to assemble leading minds to bring this emerging topic into deeper focus for the veterinary community.
“We’re bringing this powerful content to an even broader audience this year through livestreams in both Spanish and English. I’ll be hosting the English stream, and I’m excited about our plans for guest appearances from the speakers and sharing extra tidbits to make the virtual experience as engaging as it is informative.”
https://way.in/618A0oP
The company says AI Masses will allow veterinary professionals to analyse lesions suggestive of cancer in-clinic and with a fast turnaround.
The AI technology, which has been trained by human clinical pathologists, should enable individualised treatment outcomes earlier for more cases.
Zoetis says AI Masses only needs a single round of sample preparation and the results can, at additional cost, be supplemented with an expert review from a network of specialists through Zoetis’ Virtual Laboratory.
Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA, Global Chief Medical Officer at Zoetis said: “Waiting for results can be stressful for pet owners – even more so when it involves a cancer screening.
"Our research shows that up to 75% of pet owners find abnormal results highly stressful.1
"AI Masses is yet another point-of-care capability to deliver results in-clinic, further exemplifies Zoetis’ purpose to advance care for animals, shortening anxious wait times to allow for faster care decisions that help provide the best possible outcome.”
Pre-orders will be announced for US customers in Q2 2025.
VetSurgeon.org understands AI Masses will be coming to the UK some time in 2025.
https://www.zoetisdiagnostics.com
Reference
The Clinical Abstracts provide an opportunity to present new research to the wider veterinary community at Congress and Expo 2025, taking place at Manchester Central on 20th - 22nd March 2025.
Abstracts can be on any veterinary subject, whether it’s the preliminary results of a new study, a discussion of a new technique or a description of an interesting case.
Each application should be based on high-quality clinical research undertaken in industry, practice or academia, and summarised in 250 words.
Applications are welcome from veterinary surgeons, nurses, practice managers and students, with applications from those working in general practice especially encouraged.
Researchers with research of direct relevance to veterinary practice may also submit an abstract for consideration.
Andy Green, Chair of BSAVA’s Congress Committee said: “This is a fantastic opportunity for veterinary professionals to showcase their research to the global veterinary community, and a chance for delegates to learn about the latest concepts and thinkings in veterinary medicine from their peers.”
Entries for the Clinical Abstracts will close on Monday 18th November.
https://www.bsavacongress.com/clinical-abstracts
All RVNs were set an email with a voting link and a unique voter code.
The College says it will be writing to the few veterinary nurses for whom it has no unique email address with further instructions.
There are 3 candidates standing this year and you can now cast your votes for up to two of them by 5pm on Friday 26 April 2024.
The candidates are:
The individual candidate profiles are available to view at www.rcvs.org.uk/vnvote24 where you can also read the candidates’ answers to two questions of their choice submitted by the profession.
The two candidates with the most votes will join VN Council for their three-year terms at the College’s AGM in July.
Any vet nurses who have not received their voting email should contact CES directly on support@cesvotes.com.
The awards are given to practices across the UK with the most four- and five-star reviews from their clients.
To select the winners, awards organisers analyse over 10,000 reviews left by pet owners on vet practice websites over a 12 month period.
Warren House Veterinary Centre scored over 900 outstanding online reviews from clients.
Swanspool Veterinary Clinic, Northamptonshire, came in second, and Willows Veterinary Centre & Referral Service, West Midlands, third,
Winners of various sub-categories included:
Susie Samuel, CEO of VetHelpDirect.com, said: “The BestUKVets Awards were established to reward vet practices for outstanding feedback from clients.
"We are delighted for Warren House Veterinary Centre (Small Animal Services) – having read so many of their wonderful reviews, it no surprise that they won.
"Local pet owners are very fortunate to have this practice in their area”.
www.bestukvet.co.uk
Photo: vethelpdirect.com
Head of nursing services at Davies, Lillian Twigg, said: “This is a brilliant opportunity to find out what it’s like to nurse at one of the UK’s largest veterinary hospitals.
“We’re offering a tour of our state-of-the-art hospital alongside the chance to meet and chat to our team of nurses and clinicians to find out more about the different nursing roles available at Davies.
“We’re really looking forward to meeting everyone and explaining all about the nursing services at Davies Veterinary Specialists and why the work we do is so important and so rewarding.”
The open day begins at 9am with a warm welcome and refreshments, before group tours of the hospital, starting at 9.30am.
Lillian added: “There will be Q&A sessions with our nursing team at 10am and with hospital clinicians at 11am.
“There’s even a free lunch, too! It promises to be a very entertaining day that’s both a lot of fun and very informative.”
https://vetspecialists.co.uk/openday
The pack contains species-specific microchipping law guides, a practice registration guide, a cat chipping cheat sheet, flyers about registration and flyers about Identi’s silent microchipping scanner.
The company has also produced three short videos with more information for vet professionals about Identi, what it does, registering microchips and compulsory cat microchipping.
Tammie O’Leary, commercial lead at Identi, said: “From June 10th, it will be compulsory that owned cats in England are microchipped and registered in the same way.
"With these changes imminent, it is important that staff are up to date with the relevant legislation and the potential consequences of pet keepers not adhering to the law.
"identi’s new Practice Pet Protection Pack will provide busy vet professionals with comprehensive information answering a wide range of microchipping questions in a quick and simple format.”
For a copy of the Practice Pet Protection Pack, email: contact@identichip.co.uk
Faecal calprotectin is a calcium-binding protein released into the gut lumen predominantly by neutrophils, and to a lesser extent by monocytes and macrophages, during intestinal inflammation.
Its presence in faeces reflects the degree of neutrophilic infiltration in the gut mucosa, making it a useful biomarker for identifying intestinal inflammation.
Faecal calprotectin lateral flow testing is already used in human health and included in the NICE guidelines for the management of inflammatory bowel disease (IBD)1.
Determining the underlying cause of chronic diarrhoea, vomiting and weight loss in cats and dogs can be complex, often requiring invasive procedures such as endoscopy or biopsy - both of which carry cost, risk, and sometimes practical limitations in general practice.
GIQuest is designed to offer a non-invasive, rapid alternative to support clinical decision-making.
Carus says that whilst not a replacement for histopathology, faecal calprotectin concentrations have been shown to correlate with disease severity in dogs and cats, as measured by tools such as the Canine Chronic Enteropathy Clinical Activity Index (CCECAI).2
New data from the University of Bristol Vet School appears to confirm the test’s ability to differentiate dogs with histologically-confirmed inflammatory enteropathy from healthy controls with high sensitivity (94%) and specificity (96%) using a score threshold of 3mg/kg.2
Carus says the test also performed well in cats, distinguishing those with inflammatory enteropathy from healthy controls with a specificity of 100% and sensitivity of 92%.
In addition, the test detected elevated calprotectin levels consistent with inflammatory gastroenteropathy in 25% of dogs receiving oral NSAIDs, which highlights its potential not only in long-term monitoring but also early in treatment when GI side effects may first emerge.
Jolian Howell of Carus Animal Health said: “Faecal calprotectin testing can provide additional clarity in a range of clinical scenarios.
"It is particularly useful when diagnosing and managing suspected inflammatory enteropathy or food related reactions and for monitoring or screening for GI side effects of oral non-steroidal anti-inflammatories in long term OA therapy regimes.”
The Bristol study also showed that dogs with food-responsive enteropathy had a significant drop in calprotectin concentrations following dietary change, reinforcing the test’s role in tracking treatment response.
Georgie Louca, Veterinary Business Manager for Carus Animal Health, added: ”By providing a measurable, visual indicator of intestinal inflammation, GIQuest also helps support client communication and can improve compliance during treatment or dietary trials.”
GIQuest is designed for use in practice, including during consultations, delivering colour-coded results in 15 minutes.
GIQuest is now available to veterinary practices across the UK and can be ordered through veterinary wholesalers NVS, Covetrus and MWI.
https://carusanimalhealth.com/giquest
References
The authors say that whilst it has long been suspected that adverse drug reactions are under-reported, this study is the first to show the scale of the problem, using real data from veterinary clinical records.
For the study, researchers looked for electronic heath records within the Small Animal Veterinary Surveillance Network (SAVSNET) which contained “adverse drug reactions” and “side effects” in the free-text clinical narratives.
The results were then analysed to determine the suspected product, the seriousness and expectedness of the event, and whether the event had been reported to the Veterinary Medicines Directorate or Marketing Authorisation Holders.
Of the 827 cases of suspected adverse drug reactions identified out of a total of 10,565 records reviewed, approximately 90% were not reported.
74% were related to dogs and 70% were listed as “expected” (i.e. already listed in the product information).
The clinical severity of the reaction didn’t appear to impact whether it was reported.
Dr Heather Davies, lead author of the study, said: “As adverse drug reaction reporting rate is directly linked to the regulators ability to mitigate safety issues, this paper is a call to arms encouraging all veterinary professionals to report suspected adverse drug reactions and regulators to make reporting quicker and easier.
"It also the highlights the promise that big real-world data sets hold in enhancing drug safety monitoring processes.”
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13721
The RCVS says this is the first time that two leading organisations in veterinary QI are collaborating to establish a new evidence-based model for QI specific to veterinary care.
The project is being overseen by Jocelyn Toner MRCVS, an experienced veterinary surgeon with a background in shelter medicine and an interest in evidence-based interventions to improve welfare outcomes.
The team will test the model against a prevalent problem in practice and measure the cost of making the changes against the benefit it brings.
They will refine the model based on lessons learned before they make it available to all veterinary practices, to tackle any area a practice wants to improve, regardless of practice type or specialism.
The aim is to help time-poor practitioners implement proven QI methods to improve outcomes and provide a return on investment.
Jocelyn said: “I’m looking forward to working with colleagues from across the sector to develop a model that will make Quality Improvement more accessible, and show that it can have a real economic benefit.
"We know that there is increased demand for veterinary teams to provide more efficient and effective care while maintaining high levels of animal welfare, improving team welfare and client satisfaction.
"Over recent years an increasing number of veterinary teams have embraced QI techniques.
"Now is the time to take this to the next level by creating an evidence-based model for QI, which can be applied systematically in any veterinary setting.
The project will involve bringing together veterinary professionals to co-design the model and test it in practice.
If you are interested in supporting this work, please register your interest at: rcvsknowledge.org.uk/forms/ktp-interest-form/
The bursary gives Louise a £2,000 CPD allowance for having demonstrated her commitment to making a difference and furthering Louise’s legacy of sharing learning.
Louise said: “I'm absolutely over the moon to have been awarded the Louise O'Dwyer bursary - and am incredibly grateful for the support and opportunity provided by Vets Now.
"I have worked in practice for some 26 years now and was lucky enough to attend several of Louise's emergency and critical care nursing lectures at a variety of veterinary conferences over the years.
"Her lectures were inspiring and full of humour.”
“I intend to use the bursary to undertake the Post Graduate Certificate in Advanced Practice in Veterinary Nursing (PgCert APVN) through the University of Glasgow.
"I am incredibly excited to embark on this new learning journey - and hope that I can share these skills with other RVNs, and encourage others to keep following their dreams within the veterinary nursing profession, just as Louise did.”
Applications for next year’s Louise O’Dwyer bursary will open in spring 2025.
The app allows practices to submit results along with cytology and histopathology results in order to help train the AI algorithm and improve its accuracy from an original sensitivity of 85% and negative predictive value of 97%.
Liron Levy-Hirsch, Managing Director of HT Vista, said: “The HT app has provided us with over 700 additional validated scans to analyse this year alone.
"The validation process is well controlled, whereby we use the lab results to tag the scans as benign or malignant and let the algorithm know if it was correct or not.
"The more we train the algorithm the more accurate it becomes, and it is extremely exciting to see the sensitivity increase to 90% and the NPV to 98%.”
HT Vista says the app was developed to meet demand from clinics.
Liron said: "By having a portal to upload lab results alongside the device’s results not only do we further improve the device, but we also increase confidence among our vets and nurses that the device is a reliable tool.
https://ht-vista.uk
The Veterinary Wound Management Conference will be taking place at the Derby County Football Club, where there'll be workshops, demonstrations and discussions on a range of topics, from burns to post-operative care, covering dressing selection and suture techniques, complications and innovations.
There will be practical sessions on bandaging and casting and delegates will be able to choose from up to seven workshops/demonstrations at a time, on subjects ranging from eye care to maggot therapy and laser treatment.
There will also be an exhibition by companies and organisations specialising in this field.
Organisers say the venue, Pride Park Stadium, is easily accessible by road (there’s masses of free parking) and rail (it’s little more than a 10-minute well-signposted walk from the station); and there’s plenty of accommodation very close by in a Travelodge, Premier Inn, Holiday Inn Express or Penta Hotel.
For veterinary nurses, tickets cost £125 (plus VAT) for the two days or £70 (plus VAT) for one day. For vets, it's £165 for the two days or £90 (plus VAT) for one day.
The price includes a hot buffet lunch each day, morning and afternoon tea, delegate handbook and wi-fi.
Each day will provide seven hours of CPD.
To register, go to www.theveterinaryedge.com/wmc.
The survey of 1,019 dog owners was conducted by petbuzz in December 2022.
Veterinary cardiology specialist, Dr Rachel James, said: “The CKCS has long been a very popular breed of dog in high demand, due to their loving and placid nature making them perfect family pet.
"We know that sadly at least 50% of CKCS have evidence of MVD disease by the time they are five, with 98% of dogs affected in their lifetimes.
"However, we can help our clients when selecting this breed to choose a puppy that is less likely to develop MVD at an early age, by utilising the heart testing scheme (Doppler heart testing).
"Prospective owners should be asking to see test results for the parents, grandparents, and even better great grandparents too, on both maternal and paternal sides.
"In addition breeders need more support and education to encourage the use of the heart testing scheme and how this can enable them to choose the best dogs to breed from.
"Furthermore we should be encouraging breeders to breed from dogs only when they are at least 3 years of age.”
Vita Animal Health commissioned the survey to raise awareness of the condition and to remind owners to use their vet’s expertise.
Vita’s veterinary nurse, Tara Evans, said: “The CKCS is a very popular breed of dog, perhaps set to be more so now King Charles III is reigning monarch.
"This survey has shown that awareness of mitral valve disease – which is very common in this breed – is not as good as it could be.
"We want to support vets in raising awareness and have useful resources such as our heart disease infographic (www.vitaanimalhealth.com/common-signs-of-heart-disease) that we welcome all vets in using.”
The money, which was raised from the annual raffle and auction was nearly 50% more than last year's total, which was an already impressive £27,800.
When the total was announced, former Vetlife President and auctioneer for the evening, Graham Dick was visibly moved and rendered temporarily speechless.
Once he's had a chance to recompose himself, he said “Your continued selection of Vetlife as the nominated charity for your now legendary fundraising at your annual conference not only raises much needed funds to enable it to continue to fulfil its mission, but also provides an excellent opportunity to re-enforce its contribution to the wellbeing of so many fellow veterinary professionals.” \
“This amazing sum raised could not have been possible without the provision by so many of such a wide range of raffle prizes and high value lots for auction and the generosity of those who bid unstintingly for them.
"On behalf of those in our veterinary community for whom such generosity may have made a substantial difference Vetlife is extremely grateful.”
Vet Dynamics Director Vicky Robinson said: “Both Graham and I were virtually speechless to see the amazing generosity from our delegates and exhibitors and, of course, the kindness of the donors.
"It's such a pleasure to be able to contribute to a charity who work tirelessly to help our wonderful profession.”
Photo: Vicky Robinson and Graham Dick
For the study, the RVC interviewed 13 small animal general practitioners, exploring their experience of providing pre-purchase consultations for brachycephalic dogs.
The study revealed a number of barriers to delivering effective pre-purchase consultations and advice about these breeds.
They included limited time and resources, competition for appointment availability, a perception that vets are only there to fix things, public distrust of veterinary surgeons (often over money), fear of damaging vet-client relationships, and the conflicting influence of breeders and the Kennel Club on clients.
Many veterinary surgeons that took part in the research felt that they had little or no power to overcome these barriers which are highly intractable at an individual veterinarian level.
A resulting moral conflict in veterinary surgeons between their perceived ethical and moral responsibilities to animal welfare versus the needs and wants of their clients and businesses was expressed by many vets in the study, and was felt to compromise their professional integrity and autonomy.
The study set out a series of recommendations:
Dr Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science at the RVC and lead author of the study, said: “This is the first time that the impact of brachycephaly on the practising veterinary surgeon has been explored.
"Our concerning results highlight the importance of recognising that the brachycephalic crisis is not only negatively impacting animals, but it is affecting human wellbeing too.
“Our study highlights the conflict that vets are experiencing - bound both by their duty of care to their brachycephalic patients, but also to animal welfare at a population level.
"Trying to balance both of these responsibilities in the current working environment is proving very challenging for some, leading to moral distress.
"It is, therefore, essential that we protect the mental wellbeing of vets on this issue as well as from an animal welfare perspective.
“As the brachycephalic crisis continues to prevail, the support of leading veterinary organisations is vital in providing a united voice regarding the known harms of brachycephaly and support in facilitating PPCs to ensure vets are protected, and potential owners are fully informed when it comes to acquiring decisions.”
Dr Dan O’Neill, Assoc Prof of Companion Animal Epidemiology at the RVC and co-author of the study, said:
“Over the past decade, the RVC has generated a vast evidence base revealing the true extent of the serious health issues of dogs with brachycephaly.
"This new study now focuses RVC research towards protecting the wellbeing of practising veterinary surgeons who are also shown as victims of the brachycephalic crisis.
"The clear message here is that we all need to ‘stop and think before buying a flat-faced dog’.”
The Walpole Bay Tidal Pool is the biggest in the UK, covering four acres.
Everyone taking part is being challenged to raise at least £100 for Vetlife, to go towards its helpline, health support and financial support for the veterinary community.
Sea temperature at this time of year is a decidedly brisk 10 degrees Celsius, but Vetlife says the dress code is reasonably relaxed: anything from a swimming costume to a full diving dry suit!
https://events.more-human.co.uk/event/1713190086537x259173669533122560
The series will start on Sunday February 27th when Katie Ford MRCVS, who is also a life coach, will discuss the benefits of 'gratitude practice' in a 'Facebook Live' session starting at 8:00pm.
Thereafter, there will be a further seven 30-minute sessions:
Liz Barton, co-founder of WellVet, said: "We were blown away by the positive response to the Winter Wellbeing series and want to continue to build more tools and content to help people through what has already been a tough start to 2021. Our emphasis is on simple, practical, accessible tips to improve personal and team wellbeing.”
Emma McAnally, territory manager at Boehringer Ingelheim Animal Health said: “Spring is the ideal time to hit refresh on your mental and physical wellbeing. So we felt that this series will help to shed the winter blues, re-energise the team and offer an opportunity for the veterinary community to come together and take forward positive wellbeing practices. We’re delighted to support WellVet again in bringing this Spring series to life.”
For further information on the WellVet Winter Wellbeing series and for details on how to join visit www.wellvet.co.uk.
Whilst you're there, the company will doubtless use the opportunity to bend your ear about how its technology can save time, drive revenue, and strengthen patient care.
Still, all in a good cause, and the company says it expects to be making a significant donation towards supporting members of the veterinary community who are experiencing financial and mental health challenges.
ezyVet Chief Growth Officer Pete Brown said: ““As innovators in the veterinary software space, we’re passionate about bettering the lives of veterinary professionals and we recognise the critical work Vetlife is doing to support the hard-working veterinary community.
"We’re going to be donating £1 to Vetlife for every person that visits the ezyVet booth at the London Vet Show, so we encourage everyone to come down and help us support this very worthwhile cause.”
The original TATE elbow replacement was first in clinical use in the 2010s and the revised 3rd generation version is apparently a much-improved implant, something which the clinical evaluation trial should demonstrate.
Andy Moores, head of the joint replacement programme at The Moores Orthopaedic Clinic, said: “Canine elbow replacement can be a game-changer for dogs living with chronic elbow pain but up until this point the elbow replacement systems have not been as reliable as we would like.
"The third-generation TATE implant has been in use with a small number of US surgeons for several years now and the results so far have been very promising.
"We are delighted that Biomedtrix have invited us to join the evaluation trial for this implant and that the RCVS Ethics Review Panel have approved this.
"We look forward to offering this surgery as an option for some of our most painful canine patients.”
www.mooresortho.com
The materials include pet owner guides, reception posters and slides to display on waiting room TV.
They complement the Krka veterinary professional guide on responsible risk-based parasiticide use for cats and dogs that was developed in conjunction with Ian Wright BVMS MSc MRCVS and launched last year.
Renzo Di Florio, Krka’s Technical Veterinary Adviser said: “In first opinion veterinary practice, where the majority of consultations last 15 minutes or less, time is short and in-depth discussions are not always possible.
"The guides provide comprehensive information on common parasites, practical advice on prevention and treatment and information on risk assessment.
"And by aligning with ESCCAP guidelines, the guides help address the delicate balance between animal health, human health and environmental protection – a true One Health issue.”
https://www.krka.co.uk/veterinary-knowledge-hub/articles/risk-based-parasiticide-use-for-cats-and-dogs
Senior educators came from both UK and international veterinary and nursing schools to discuss and agree approaches to teaching contextualised care in first opinion practice for the first time.
The workshop aimed to give delegates an understanding of what contextualised care is and why it is important.
It also covered the types of clinical training settings that are conducive to supporting contextualised care learning.
Delegates then discussed the challenges associated with contextualised care learning in community-based clinical training settings.
They included: perceived conflicts between educational and commercial interests, a lack of previous formal teaching of contextualised care (during education), and the absence of established culture (and experience) of undergraduate teaching in clinical practice.
Workshop co-presenter and CVS’ Equine Development Lead Charlotte Sinclair, said: “Most veterinary graduates will enter primary care practice upon graduation and we know the majority of new graduates and employers agree that graduates are not prepared to practice contextualised care. The consequences of not being prepared include a tension between presumed ‘gold standard’ and the realities of practice, stress and moral distress.
“We hope that our landmark workshop will go some way towards helping trainers to support graduates in developing authentic communication skills, building client rapport, creating shared decision making, and being outcome focused. As true contextualised care relies on all of these skills.”
Available in packs of 56 (4 x 14 tablet blister packs), Lodisure tablets are divisible for accurate dosing.
The recommended starting dose is 0.125-0.25 mg amlodipine per kg bodyweight per day, which equates to half a tablet for cats weighing less than 4kg (and more than 2kg) and one tablet per day for cats weighing between 4kg and 8kg.
It can be administered directly to the cat or given with a small quantity of food.
Dechra companion animal brand manager, Sarah Musgrave, said: “Feline hypertension is very often part of a more complex diagnosis, therefore it is important that antihypertensive therapies are easy to dose and administer.
"Lodisure is a new, first-line, easy to dose and administer treatment to control systolic blood pressure in cats while the underlying primary cause is diagnosed and treated, which vets can rely on in their day-to-day practice.”
https://www.dechra.co.uk/products/cat/prescription/lodisure.
The association began to produce client information leaflets in 2011, to help its members provide information to clients about the safe use of the drugs that they prescribe and dispense for the patients under their care. Over the years the range of leaflet groups has expanded to include canine and feline behaviour and exotic pets, as well as medicines.
Designed to be printed easily in practice, all the leaflets have the option to add practice details if required. The new additions for June are Antihistamines, Ferrous sulphate, Fluconazole, Hydrochlorothiazide, Imipramine, Leflunomide, Travoprost and Trimethoprim/Sulphonamide, with authors including Polly Frowde, Hannah Hodgkiss-Geere, and Fergus Allerton.
Julian Hoad, Chair of the Publications Committee said: “We are proud to have hit this impressive milestone; we know that our client information leaflets are of great use to our members to help them keep their clients informed and we aim to add to this number every year.”
The client information leaflets are provided to BSAVA members as part of their member benefits and are also available for non-members to buy as part of the ‘Formulary Plus’ online subscription. You can find them in the BSAVA Library here.